National Health Investors Inc

National Health Investors Inc(NHI)股票分析

$66.350

+1.692 (+2.55%)收盤時

Loading chart…
最高
66.410
開盤
65.330
成交量加權均價
65.95
成交量
273.22K
市值
2.93B
最低
65.085
成交金額
18.02M
企業價值/稅息折舊攤銷前利潤(TTM)
15.44

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has over 176 healthcare real estate properties located in 32 states and leased primarily pursuant to triple-net leases to 31 tenants. The SHOP segment consists of two ventures that own the operations of independent living facilities. This segment has over 26 senior housing communities located in 13 states with a combined 3,009 units.

AI 分析 of National Health Investors Inc (NHI)

買進

National Health Investors Inc is a good buy right now due to its current price of $66.28, which is significantly below the average analyst price target of $79. Additionally, the company reported a strong earnings per share of $1.15 in Q2, reflecting a 45.6% year-over-year increase, indicating robust profitability. The primary risk is the recent decline in stock performance, with a year-to-date change of -13.75%, suggesting potential volatility ahead.

分析師評級(12)

上檔空間 +28.76%
持有
2 買進
9 持有
1 賣出
目前: 66.35
最低
77.00
平均
85.43
最高
90.00

Huntington

2026-09-10

目標價

$79

優於大盤

Huntington

2026-09-09

目標價

$79

優於大盤

Truist

2026-09-02

目標價

$80

買進

Wells Fargo

2026-09-01

目標價

$78

Equal Weight

BofA

2026-08-24

目標價

$86

買進

估值指標

National Health Investors Inc(NHI)目前預期本益比為 18.15,5 年平均預期本益比為 20.89。

預期本益比

合理
5 年均值 P/E
20.89
目前P/E
18.15
高估
23.95
低估
17.84

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.92
目前EV/EBITDA
15.44
高估
16.25
低估
13.59

預期股價營收比

低估
5 年均值 P/S
8.60
目前P/S
6.71
高估
9.75
低估
7.46

Alphio AI 對 NHI 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%NHI

$74.94

情境價格

基

基準

基準 · 50%NHI

$72.59

情境價格

悲

悲觀

悲觀 · 25%NHI

$68.11

情境價格

持有 NHI 的大戶

B

BNY Mellon ETF Investment Adviser, LLC

+ 持有NHI

+5.42%

3個月報酬率

事件時間軸

2026-10-01 (ET)

07:30:00

National Health Investors Invests $107.7M to Acquire Six Properties

2026-08-10 (ET)

16:30:00

NHI Reports Q2 Revenue of $121.32M, Beating Expectations

16:30:00

Company FY26 Guidance Includes $180M in New Investments

2026-07-27 (ET)

06:30:00

National Health Investors Appoints Chris Maingot as COO

2026-06-23 (ET)

20:30:00

Tech Stocks Plummet Due to Valuation Concerns

資訊

NHI 常見問題 —— 由 Alphio AI 解答

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has over 176 healthcare real estate properties located in 32 states and leased primarily pursuant to triple-net leases to 31 tenants. The SHOP segment consists of two ventures that own the operations of independent living facilities. This segment has over 26 senior housing communities located in 13 states with a combined 3,009 units. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

National Health Investors Inc is a good buy right now due to its current price of $66.28, which is significantly below the average analyst price target of $79. Additionally, the company reported a strong earnings per share of $1.15 in Q2, reflecting a 45.6% year-over-year increase, indicating robust profitability. The primary risk is the recent decline in stock performance, with a year-to-date change of -13.75%, suggesting potential volatility ahead.

12 analysts cover NHI: 2 rate it Buy, 9 Hold and 1 Sell. The average price target is 85.43.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易